Craig A. Johnson, Director at Mirati Therapeutics, Inc. (MRTX), sold 15,000 shares at $93.00 ($1.4M) on 2020-04-20, disclosed to the SEC on 2020-04-21.
Open-market sale of $1.4M MRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| HRTX | SELL | 2021-06-22 | $4K | — | Filing → |
| HRTX | SELL | 2021-04-07 | $4K | — | Filing → |
| MRTX | SELL | 2021-01-25 | $6.3M | — | Filing → |